Which statement about amiodarone dosing for pediatric refractory VF/pVT is correct?

Which statement about amiodarone dosing for pediatric refractory VF/pVT is correct?

• A. The recommended dose is 5 mg/kg IV/IO; may repeat once for a total up to 15 mg/kg
• B. The recommended dose is 10 mg/kg IV/IO; may repeat once for total up to 20 mg/kg
• C. The recommended dose is 1 mg/kg IV/IO; may repeat with a smaller second dose
• D. The recommended dose is 15 mg/kg IV/IO; may repeat twice for a total 30 mg/kg

Answer: (A)

The key idea here is using a weight-based antiarrhythmic dose for pediatric refractory VF/pVT that balances effectiveness with safety. In children, the recommended approach is a bolus of amiodarone at 5 mg/kg given IV or IO during CPR, and you may give a second bolus of the same dose if the rhythm remains unstable, for a total maximum of 15 mg/kg. This limit helps minimize risks such as hypotension, bradycardia, QT prolongation, and other toxicities while providing a meaningful antiarrhythmic effect. Why the other dosing patterns don’t fit: starting with a higher initial dose, like 10 mg/kg, would push the total dose beyond the guideline maximum (up to 20 mg/kg total), increasing toxicity risk and not aligning with recommended practice. A very small dose, such as 1 mg/kg, is unlikely to control a refractory rhythm. Assigning a large initial dose like 15 mg/kg with the plan to repeat twice to reach 30 mg/kg would vastly exceed safe total exposure per arrest. So, the correct concept is a 5 mg/kg bolus, repeatable once for a total of up to 15 mg/kg.

The key idea here is using a weight-based antiarrhythmic dose for pediatric refractory VF/pVT that balances effectiveness with safety. In children, the recommended approach is a bolus of amiodarone at 5 mg/kg given IV or IO during CPR, and you may give a second bolus of the same dose if the rhythm remains unstable, for a total maximum of 15 mg/kg. This limit helps minimize risks such as hypotension, bradycardia, QT prolongation, and other toxicities while providing a meaningful antiarrhythmic effect.

Why the other dosing patterns don’t fit: starting with a higher initial dose, like 10 mg/kg, would push the total dose beyond the guideline maximum (up to 20 mg/kg total), increasing toxicity risk and not aligning with recommended practice. A very small dose, such as 1 mg/kg, is unlikely to control a refractory rhythm. Assigning a large initial dose like 15 mg/kg with the plan to repeat twice to reach 30 mg/kg would vastly exceed safe total exposure per arrest.

So, the correct concept is a 5 mg/kg bolus, repeatable once for a total of up to 15 mg/kg.